Porosome Therapeutics Leadership Meets with the Principal Scientific Adviser to the Government of India
Porosome Therapeutics, Inc. has partnered with India to co-develop and license novel drugs targeting cellular secretory dysfunctions. Company leadership, including Chairman Prof. Bhanu P. Jena, recently met with the Principal Scientific Adviser to the Government of India, Prof. Ajay Sood, to align ongoing R&D initiatives with national healthcare and emerging technologies like AI.